MINNEAPOLIS--(BUSINESS WIRE)--Smiths Medical announces a strategic decision to serve our non-hospital-based infusion customers through a new distribution model that simplifies the way providers order, receive and deliver care with CADD® infusion therapy products.
Smiths Medical CADD® infusion systems will only be available to non-hospital-based infusion providers through three distributors: InfuSystem, Integrated Medical Systems, Inc. (IMS), and a preferred partnership with Medical Specialties Distributors (MSD).
“This new model will enhance our ability to focus on expanding our technologies, and bringing enhanced solutions to market,” said Carl Stamp, Vice President Global Marketing and Strategy, Smiths Medical. “Selecting MSD as our preferred distribution partner provides a single-source service model, improving patient satisfaction and lowering the total cost of care.”
“MSD provides the widest purchase options to meet the business needs for infusion providers,” said Keith Crawford, Chief Strategy Officer, MSD. “Smiths Medical’s infusion systems combined with our distribution, device, and technology offers best in class solutions for the customers we serve.”
By working together, this model offers providers the power of partnership with the right technology solutions working in harmony to enhance productivity, reduce costs, and improve patient satisfaction.
About Smiths Medical
Smiths Medical www.smiths-medical.com is a leading manufacturer of specialized medical devices and equipment for global markets, focusing on the medication delivery, vital care and safety devices market segments. It is part of Smiths Group www.smiths.com, a global leader in applying advanced technologies from markets in threat and contraband detection, energy, medical devices, communications and engineered components. Smiths Group employs around 23,000 people in more than 50 countries.
